🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Presenting PICOLLA study joining COLOPEC trial and HIPECT4 trial. HIPEC prevent recurrences in right-t4 advanced colon cancer Peritoneal Surface Oncology Group International European Society of Surgical Oncology (ESSO) ISSPP SEOQ | Los cirujanos del cáncer #operarelcancer Kiran Turaga Delia Cortés Guiral Martin Hübner IMIBIC Hospital Universitario Reina Sofía

New review paper - Pathophysiology of Peritoneal Metastasis @DemuytereJesse @sernst ISSPP onlinelibrary.wiley.com/doi/10.1002/js…

Led by @LahayeMax on behalf of the Peritoneal Surface Oncology Group International and ESGAR, the guidelines on imaging for peritoneal metastases of colorectal and ovarian origin are now available link.springer.com/article/10.100… 🔓 Open access with Ignace de Hingh #PascalRousset Artem Stepanyan #StephanieNougaret

2️⃣days before #NETCancerDay🦓 Guidance on biomarkers🧬🧪☢️ Many markers prognostic ▪️& Rx-informing: Ki67, SSTR uptake, 5hiaa ▫️not Rx-informing: NGS, TMB, NETPET score ▪️for research only: MGMT, pancreastatin, NSE, transcriptomics ▫️in development: liquid bx🩸 More in📝👇🏻

✨Prepare with Confidence for the CGSO Board Exam✨ The one-day Virtual CGSO Board Exam Review Course will provide a comprehensive review of the most relevant information to help better prepare you for the exam. Register now: ow.ly/gx8f50UpbRC

My🔝10📝of2⃣0⃣2⃣4⃣(cont'd) NETTER 2 in The Lancet RCT - ☢️PRRT vs long-acting SSA in G2/3 advanced GEP-NETs ⬆️PFS by >12 months median HR 0.28 (0.18–0.42) Across all sub-groups 💥 New standard of care for 2025? 🦓 thelancet.com/journals/lance…

The Society of Surgical Oncology (SSO) is pleased to announce the following new Officer and Board Members set to join the Board of Directors for the 2025-2028 term. To learn more please visit: ow.ly/UgZj50Uv2Y1

🦓Appendiceal NETs - exceedingly rare stage IV From single-centre Moffitt Cancer Center 👥124 over 15 years ‼️10 stage IV👉🏻 8 synchronous Spread is rare - worth putting patients through right hemicolectomy ? Just in time for NANETS experts statement pubmed.ncbi.nlm.nih.gov/39705801/😃

What did you ask Santa for this year? 🎅🏻🎁 #CalvinandHobbes #Christmas

This looks amazing! 😍#CalvinandHobbes

#ACT2025 serves as a comprehensive forum to promote research, development and application of advanced cancer therapies. This event promotes education and the exchange of information among professionals regarding advanced cancer therapies. Join us: ow.ly/MB0s50UtILZ

GEP‐NETs are the 2nd most prevalent neoplasm of gastrointestinal origin after #ColorectalCancer. AJCC outlines their version 9 updates, including advocating against the use of serum chromogranin A for the diagnosis & monitoring of GEP‐NETs. Read at: acsjournals.onlinelibrary.wiley.com/doi/full/10.33…

Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma ⁦SURGERY Journal⁩ surgjournal.com/article/S0039-…

Resect or ablate small CRLM?🧐 💥COLLISION trial - stopped early 👥300 pts with <=10 mets <=3cm Ablation🆚Resection ⬇️morbidity w ablation - 19 vs 46% ✅OS non-inferior No diff local control Where do we go next - new SOC?🤯 Join #SSO2025 to hear Åsmund A. Fretland on this topic!

We love connecting and celebrating the 2025 Research Awards, Gabrielle Graham Award, and Travel Award recipients at the Meet the Professors event sponsored by A.C.P. #ACT2025

#CalvinandHobbes

SSO Education has a new home! We are excited to announce the launch of SurgOnc Academy to provide a more dynamic and user-friendly platform for all of your surgical oncology education needs! Log in with your SSO credentials at learn.surgonc.org

The Society of Surgical Oncology is pleased to announce the newly installed Officers and Board Members as they officially begin their term for the 2025-2026 governance year. Please join us in welcoming them! ow.ly/sWLx50Vsw6g

🚨 Start your free trial today! SurgOnc Academy is open to everyone through December 31, 2025. Beginning January 2026, access becomes a member-only benefit—don’t miss your chance to explore the platform now. Start learning: ow.ly/99aL50VFu1x

Symptoms & quality of life are key in #NETs care New tools🧰 from @asco for symtpom management in well-diff GEP-NETs ☑️carcinoid syndrome, carcinoid heart disease, carcinoid crisis & functional PNETs ☑️surgrery, liver-directed therapy & systemic 🔗📝ascopubs.org/doi/10.1200/OP…